Steris STE

• Nov 4, 2026 RestructuringReported exit or disposal costs from a restructuring 8-K item 2.05 · all documents
• Aug 5, 2026 RestructuringReported exit or disposal costs from a restructuring “Costs Associated with Exit or Disposal Activities. On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina. The investment is expected to accelerate innovation, expand capacity and optimize our U.S. chemistries manufacturing…” 8-K item 2.05 · all documents
• Aug 6, 2025 CEO, CFO, COO or CAOCFO change “Tokich notified the Board of Directors (the “Board”) of his resignation from his current role as Senior Vice President and Chief Financial Officer of the Company.” 8-K item 5.02 · all documents
• May 8, 2024 RestructuringReported exit or disposal costs from a restructuring “Costs Associated with Exit or Disposal Activities. On May 8, 2024, the Company announced a targeted restructuring plan (the “Restructuring Plan”), which includes restructuring of the Healthcare surgical business in Europe as well as other actions, including the impairment of an internally developed X- ray accelerator, product rationalizations and facility consolidations. STERIS began broadly…” 8-K item 2.05 · all documents

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.